The Europe IV Equipment Market size is valued at USD 3.22 billion in 2021 and is expected to grow at a CAGR of 5.5%, to reach USD 4.21 billion by 2026 during the forecast period 2021 to 2026.
Intravenous (IV) prescriptions are a course of action controlled particularly into the venous spread through a syringe or intravenous catheter (tube). Intravenous treatment is the flood of liquid parts clearly into a vein. Intravenous (IV) means inside vein. The intravenous course is the fastest way to deal with transport fluids and arrangements wherever all through the body. The Europe IV Equipment market is emerging at a remarkably rapid speed.
Diabetes, gastrointestinal maladies, ascend in a tumor, neurological conditions, and unhealthiness; an upsurge in human services spending and improvement of medicinal services are major drivers affecting business sector advancement, particularly in rising nations. The elderly population and expanded access to palliative care keeps on driving interest for IV gear for medication and supplement implantation. Working on various government activities will likewise drive up a selection of intravenous administration of maladies.
Europe IV Equipment Market has been segmented and sub-segmented into the following categories:
On the basis of product type, the IV catheters segment is expected to have the major share of the IV Equipment Market in 2018.
Top Companies leading the Europe IV Equipment Market are ICU Medical, Inc. (U.S.), Smiths Medical (U.K.), Moog, Inc. (U.S.), Becton, Dickinson, and Company (U.S.), B. Braun Melsungen AG (Germany), Baxter International Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan.), C. R. Bard, Inc. (U.S.).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 IV Catheters
5.1.2 Administration Sets
5.1.3 Infusion Sets
5.1.4 Securement Devices
5.1.5 Stopcocks and Check Valves
5.1.6 Drip Chambers
5.1.7 Needleless Connectors
5.1.8 Other IV Equipment
5.1.9 Y-o-Y Growth Analysis, By Product
5.1.10 Market Attractiveness Analysis, By Product
5.1.11 Market Share Analysis, By Product
5.2 End User
5.2.1 Hospitals and Clinics
5.2.2 Home Care
5.2.3 Ambulatory Care Centers
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Becton
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Dickinson and Company (U.S.)
8.3 B. Braun Melsungen AG (Germany)
8.4 Baxter International Inc. (U.S.)
8.5 Fresenius SE & Co. KGaA (Germany)
8.6 ICU Medical, Inc. (U.S.)
8.7 Smiths Medical (U.K.)
8.8 Moog, Inc. (U.S.)
8.9 Terumo Corporation (Japan.)
8.10 C. R. Bard, Inc. (U.S.)
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
